Praecis Plenaxis Medicare Coverage Policy Limits Payment To Approved Uses
Executive Summary
The Centers for Medicare & Medicaid Services national coverage decision for Praecis' prostate cancer drug Plenaxis restricts reimbursement to within FDA approved uses